Plasma-prolactin in human breast cancer

Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.

European journal of cancer (Oxford, England : 1990)·2004

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences.

European journal of cancer (Oxford, England : 1990)·2003

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies.

Journal of cancer research and clinical oncology·2000

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

Human gene therapy·2000

[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].

Nederlands tijdschrift voor geneeskunde·1999

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

The diagnostic and prognostic role of miRNA-21 and miRNA-223 in laryngeal squamous cell carcinoma: A systematic review with exploratory meta-analysis.

The Medical journal of Malaysia·2026

The impact of lymphovascular space invasion on recurrence and survival rate among women with stage I endometrioid endometrial cancer.

The Medical journal of Malaysia·2026

Cardiac Remodeling Trajectory and Renal Stage-Specific Risk Stratification in East Asian Fabry Disease Patients.

JACC. Asia·2026

Cost-Effectiveness Analysis of Fecal Immunochemical Test-based Versus Total Colonoscopy-Based Colorectal Cancer Screening in Japan: A Microsimulation Study.

Value in health regional issues·2026

Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer.

Clinical and translational science·2026

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

Tumori·2026

Related Experiment Videos

Plasma-prolactin in human breast cancer

Related Concept Videos

Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.

Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients. clinical outcomes and oncologists' preferences.

Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies.

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

Vaccination of melanoma patients with an allogeneic, genetically modified interleukin 2-producing melanoma cell line.

[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

The diagnostic and prognostic role of miRNA-21 and miRNA-223 in laryngeal squamous cell carcinoma: A systematic review with exploratory meta-analysis.

The impact of lymphovascular space invasion on recurrence and survival rate among women with stage I endometrioid endometrial cancer.

Cardiac Remodeling Trajectory and Renal Stage-Specific Risk Stratification in East Asian Fabry Disease Patients.

Cost-Effectiveness Analysis of Fecal Immunochemical Test-based Versus Total Colonoscopy-Based Colorectal Cancer Screening in Japan: A Microsimulation Study.

Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer.

A radiomic approach to non-invasively decode tumor immune microenvironmental features in surgically resected non-small cell lung cancer.

Related Experiment Videos

Plasma-prolactin in human breast cancer

Related Concept Videos

Related Articles